Authors:
Chamoun, V
Zeman, A
Blennow, K
Fredman, P
Wallin, A
Keir, G
Giovannoni, G
Thompson, EJ
Citation: V. Chamoun et al., Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF, J NEUR SCI, 182(2), 2001, pp. 117-121
Authors:
Rees, JH
Hain, SF
Johnson, MR
Hughes, RAC
Costa, DC
Ell, PJ
Keir, G
Rudge, P
Citation: Jh. Rees et al., The role of [F-18]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders, BRAIN, 124, 2001, pp. 2223-2231
Authors:
Aebi, M
Helenius, A
Schenk, B
Barone, R
Fiumara, A
Berger, EG
Hennet, T
Imbach, T
Stutz, A
Bjursell, C
Uller, A
Wahlstrom, JG
Briones, P
Cardo, E
Clayton, P
Winchester, B
Cormier-Daire, V
de Lonlay, P
Cuer, M
Dupre, T
Seta, N
de Koning, T
Dorland, L
de Loos, F
Kupers, L
Fabritz, L
Hasilik, M
Marquardt, T
Niehues, R
Freeze, H
Grunewald, S
Heykants, L
Jaeken, J
Matthijs, G
Schollen, E
Keir, G
Kjaergaard, S
Schwartz, M
Skovby, F
Klein, A
Roussel, P
Korner, C
Lubke, T
Thiel, C
von Figura, K
Koscielak, J
Krasnewich, D
Lehle, L
Peters, V
Raab, M
Saether, O
Schachter, H
Van Schaftingen, E
Verbert, A
Vilaseca, A
Wevers, R
Yamashita, K
Citation: M. Aebi et al., Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG, GLYCOBIOLOG, 10(6), 2000, pp. III-V
Citation: G. Giovannoni et al., Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis, ANN NEUROL, 47(5), 2000, pp. 684-685
Authors:
Imtiaz, F
Worthington, V
Champion, M
Beesley, C
Charlwood, J
Clayton, P
Keir, G
Mian, N
Winchester, B
Citation: F. Imtiaz et al., Genotypes and phenotypes of patients in the UK with carbohydrate-deficientglycoprotein syndrome type 1, J INH MET D, 23(2), 2000, pp. 162-174